p53 Status and Gene Transfer Experiments Using CMV Enhancer/Promoter
- 12 January 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 280 (1) , 45-47
- https://doi.org/10.1006/bbrc.2000.4029
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- p53 deficiency and misexpression of protein kinase CK2α collaborate in the development of thymic lymphomas in miceOncogene, 1998
- Promoter Attenuation in Gene Therapy: Interferon-γand Tumor Necrosis Factor-αInhibit Transgene ExpressionHuman Gene Therapy, 1997
- EDITORIAL. p53—INTEGRATING THE COMPLEXITYThe Journal of Pathology, 1996
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- Wild-type p53 can down-modulate the activity of various promoters.Proceedings of the National Academy of Sciences, 1991
- Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product.Proceedings of the National Academy of Sciences, 1991